Institutional investors purchased a net $1.6 million shares of CYTR during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 37.56% of shares outstanding that institutional investors hold is actually below the Pharmaceuticals: Other industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
LEHMAN FINANCIAL RESOURCES, INC. Bought 500.00 shares of CytRx Corp
ARIEL CAPITAL ADVISORS LLC Bought 500.00 shares of CytRx Corp
NEXT FINANCIAL GROUP, INC. Bought 250.00 shares of CytRx Corp